Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

31. Décembre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2932


	Articles 1 - 20 / 58627

	Long-Term Survival With Olaparib Maintenance Therapy in Metastatic Pancreatic Carcinoma of a Patient Harboring Germline BRIP1 and ATM Mutations. Case Rep Oncol Med Birhiray RE, Birhiray MN, Ranger SL, Flanders VL. PMID: 41473825 [PubMed]
	Nutrient-stimulated Hormone-based Therapies: A New Frontier in the Prevention and Management of MASH-associated Hepatocellular Carcinoma. J Clin Transl Hepatol Phillips R, Ma YT, Hanif W, Shah T, Sivakumar S. PMID: 41473259 [PubMed]
	Construction of 3D Enhanced CT Radiomics-Based Model to Predict Circadian Gene Expression and Prognosis in Hepatocellular Carcinoma. J Hepatocell Carcinoma Zhao J, Zhou H, Wang C, Zhang W, Pang Y, Zheng H, Zhang L, Zhou J, Hu Z. PMID: 41472915 [PubMed]
	Role of Probiotics in Enhancing Immune Function and Improving the Effectiveness of Treatments for Pancreatic Cancer. Microorganisms Kaur K. PMID: 41471890 [PubMed]
	Nutritional Support for Gastrointestinal Cancer Patients: New (and Old) Frontiers in Management, a Narrative Review. Nutrients Khajoueinejad N, Santiago C, Turner K, Pimiento JM. PMID: 41470862 [PubMed - indexed for MEDLINE]
	Long-Term Cancer Incidence Trends in Korea (2001-2020): An Age-Period-Cohort and Joinpoint Analysis with a Focus on Younger Cohorts. Medicina (Kaunas) Lee H, Kim M, Song G, Joung JY, Seo H, Yoon JH, Chung J. PMID: 41470181 [PubMed - indexed for MEDLINE]
	Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Study. Cancer Med Wansch K, Schneider F, Dölvers F, Kühn A, Dragomir MP, Joosten M, Hilfenhaus G, Vecchione L, Felsenstein M, Lerchbaumer M, Jürgensen C, Bahra M, Duwe G, Schäfer R, Stintzing S, Keilholz U, Neumann CCM, Pelzer U. PMID: 41469727 [PubMed - indexed for MEDLINE]
	Gut microbiota reshaping the pancreatic cancer immune microenvironment: new avenues for immunotherapy. Mol Cancer Zheng SH, Li KZ, Feng G, Wang YT, Wang JN, Li SQ, Sun YD. PMID: 41469665 [PubMed - indexed for MEDLINE]
	Artery-first Approach Versus Standard Pancreaticoduodenectomy: A Systematic Review and Meta-analysis of Surgical Outcomes and Oncological Benefits. Anticancer Res Skandalakis M, Gonidakis N, Koundouraki M, Mplevrakis E, Theodoridou S, Moris D. PMID: 41469139 [PubMed - indexed for MEDLINE]
	Impact of Polymeric Formula on Outcomes in Robotic Pancreatectomy: A Randomized Controlled Trial. Anticancer Res Takagi K, Fuji T, Yasui K, Yamada M, Nishiyama T, Nagai Y, Hashimoto M, Mitsuhashi T, Fujiwara T. PMID: 41469113 [PubMed - indexed for MEDLINE]
	Short-term Outcomes of Robotic-assisted Versus Laparoscopic Right Hemicolectomy for Right-sided Colon Cancer: A Retrospective Study. Anticancer Res Narihiro S, Kitaguchi D, Ryu S, Fukuda M, Kamada T, Nakashima S, Kumamoto T, Toya N, Eto K. PMID: 41469105 [PubMed - indexed for MEDLINE]
	Inter-fractional Variation of Linear Energy Transfer Profiles During Carbon-ion Radiotherapy for Pancreatic Cancer. Anticancer Res Yoshimatsu Y, Oike T, Sakai M, Miyasaka Y, Yoshida H, Ohno T. PMID: 41469104 [PubMed - indexed for MEDLINE]
	High Incidence of Asymptomatic Pulmonary Embolism Detected on Early Postoperative CT After Thoracoscopic Esophagectomy for Esophageal Cancer: A Prospective Observational Study. Anticancer Res Nakamura S, Kitazawa M, Yamamoto Y, Miyazaki S, Hondo N, Kataoka M, Tanaka H, Ishizaka N, Shimizu T, Soejima Y. PMID: 41469096 [PubMed - indexed for MEDLINE]
	Intraductal Papillary Mucinous Neoplasms (IPMN): An Overall Review and a Retrospective Analysis of 22 Patients. Anticancer Res Nardi P, Varcasia E, Rinaldi V, Pasqua R, Coletta E, Saullo P, Caronna R, Casella G, Gissey LC, Prezioso G, D'Andrea V, Angrisani M, Meniconi RL, Illuminati G, Ettorre GM. PMID: 41469095 [PubMed - indexed for MEDLINE]
	Evaluation of Regorafenib-induced Pancreatic Enzyme Elevation in Metastatic Colorectal Cancer Treatment. Anticancer Res Ohtaki KI, Takeuchi R, Iwayama K, Chuma M, Tasaki Y, Saito Y. PMID: 41469090 [PubMed - indexed for MEDLINE]
	The basis for future personalized therapy approaches - Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients. Eur J Cancer Schneider F, Chen H, Pelzer U, Compton RG, Duwe G, Dragomir MP, Hilfenhaus G, Vecchione L, Alig A, Felsenstein M, Lerchbaumer M, Rieke DT, Bahra M, Kutsche R, Tschulik K, Stintzing S, Keilholz U, Neumann CCM. PMID: 41468770 [PubMed - as supplied by publisher]
	Matrine and Its Derivatives: Multi-Pathway Regulation in Cancer Therapy. Cancer Manag Res Xiong Z, Pu J. PMID: 41467103 [PubMed]
	Deep learning based on ultrasound for differential diagnosis of pancreatic serous cystic neoplasm and mucinous cystic neoplasm. BMC Cancer Yuan Z, Shi Y, Chen S, Yang J, Chen J, Li J, Pu Y, Ma X, Yang Q, Zhao X, Mou L, Shi Y, Luo Y. PMID: 41466236 [PubMed - in process]
	Skeletal muscle mass associates with pancreaticoduodenectomy operative time in a sex-dependent manner. BMC Cancer Xiao S, Freeman A, Kalmanek E, Steckly K, Belding-Schmitt M, Chan CHF, Talbert EE. PMID: 41466196 [PubMed - indexed for MEDLINE]
	Prognostic Value of CONUT and ALBI in Metastatic Pancreatic Cancer: A Retrospective Cohort Study. Diagnostics (Basel) Peker P, Geçgel A, Y, C, Selvi S, Bozkurt Duman B, Çil T. PMID: 41464163 [PubMed]

Articles 1 - 20 / 58627

Page 1 de 2932



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité